Filing excerpt
The Company drew down the full $6.0 billion of funds under the facility to fund a portion of the approximately $6.8 billion cash consideration for the acquisition of Terns.
What this signalsIntegration work after a deal often opens needs for new systems and services.
Vendors
Vendors named
sec-10qacquisitionCompletedGet every 10-Q signal for Merck and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Merck this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/9f4f5c47-2e01-44cb-bf5d-f76efa59dd2d returns this record as JSON. POST /v1/companies/enrich returns every signal for merck.com.
{
"signal_id": "9f4f5c47-2e01-44cb-bf5d-f76efa59dd2d",
"signal_type": "sec-10q",
"signal_subtype": "acquisitionCompleted",
"detected_at": "2026-08-11T08:11:50.628+00:00",
"company": {
"name": "Merck",
"domain": "merck.com"
},
"data": {
"detail": "The acquisition of Terns Therapeutics for approximately $6.8 billion significantly increases Merck's debt and creates an urgent need for seamless integration of financial, operational, and R&D systems to realize value from the deal.",
"metrics": {
"timeframe": "current_quarter",
"dollar_context": "Cash consideration for the acquisition of Terns",
"dollar_millions": 6800
},
"summary": "Merck completes ~$6.8B acquisition of Terns, funded by $6B in new debt.",
"excerpts": "The Company drew down the full $6.0 billion of funds under the facility to fund a portion of the approximately $6.8 billion cash consideration for the acquisition of Terns.",
"relevance": 0.9,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/310158/000031015826000212/mrk-20260630.htm",
"filing_date": "2026-08-07",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "06/30",
"sales_relevance": "Active integration needs",
"signal_category": "strategic",
"vendors_mentioned": [
"Terns Pharmaceuticals, Inc.",
"Cidara Therapeutics, Inc."
]
}
}
curl https://signals.autobound.ai/v1/signals/9f4f5c47-2e01-44cb-bf5d-f76efa59dd2d \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"merck.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.